• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Chromosome X AlphaSatellite in FITC Spectrum

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall Chromosome X AlphaSatellite in FITC Spectrumsee related information
Date Initiated by FirmMarch 19, 2021
Create DateApril 26, 2021
Recall Status1 Open3, Classified
Recall NumberZ-1493-2021
Recall Event ID 87621
Product Classification Reagents, specific, analyte - Product Code MVU
ProductChromosome X Alpha-Satellite in FITC Spectrum - Product Usage: Analyte Specific Reagents. Model: MPA3481
Code Information Lot: RD20/253/16, RD21/043/01, RD21/043/02
Recalling Firm/
Manufacturer
Cytocell Ltd.
418 Cambridge Science Park, Milton Road
Oxford Gene Technology
Cambridge United Kingdom
For Additional Information ContactAysel Parr Heckel
914-467-5285
Manufacturer Reason
for Recall
Users may observe additional locus specific signals at 9q34. The device pack insert indicates the probe has no known cross-reactivity to 9q34.
FDA Determined
Cause 2
Under Investigation by firm
ActionOn 3/19/2021, Cytocell issued an Urgent Medical Device Recall notice via email notifying customers they may observe additional locus specific signals at 9q34. The device pack insert indicates the probe has no known cross-reactivity to 9q34.
Quantity in Commerce89 probes
DistributionUS Nationwide distribution in the states of TX, OH, NY, IL, CT, AL, IA, MO.
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
-
-